FOXO TECHNOLOGIES INC. Investing Cash Flow
FOXO TECHNOLOGIES INC. (FOXO) reported Investing Cash Flow of -$9.37 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$5.38K.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$4.00K.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$18.74K.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$621.97K, a 328.26% decline year-over-year.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) investing activities for fiscal 2025 was -$655.61K, a 5018.64% decline from fiscal 2024.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) investing activities for fiscal 2024 was $13.33K.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) investing activities for fiscal 2022 was -$1.87M.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) investing activities for fiscal 2021 was -$355.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 8 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$9.37K 10-Q · filed 2026-08-14 | -$28.11K derived: sum of 3 quarters · filed 2026-08-14 | -$650.08K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$4.00K 10-Q · filed 2026-05-15 | -$22.74K derived: sum of 2 quarters · filed 2026-05-15 | -$644.70K derived: sum of 3 quarters · filed 2026-05-15 | ||||
| 2025-12-31 | -$18.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$640.71K derived: sum of 2 quarters · filed 2026-04-15 | -$655.61K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$621.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$636.87K 10-Q · filed 2025-11-10 | |||||
| 2025-06-30 | -$14.90K 10-Q · filed 2026-08-14 | ||||||
| 2024-12-31 | -$336.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $272.14K derived: sum of 2 quarters · filed 2026-04-15 | $2.14M derived: sum of 3 quarters · filed 2026-04-15 | $13.33K 10-K · filed 2026-04-15 | |||
| 2024-09-30 | $272.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.14M derived: sum of 2 quarters · filed 2025-11-10 | $13.66K 10-Q · filed 2025-11-10 | $14.00K 10-Q · filed 2024-11-19 | |||
| 2024-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$258.81K 10-Q · filed 2025-08-19 | -$2.38M 10-Q · filed 2024-08-19 | ||||
| 2024-03-31 | -$2.12M 10-Q · filed 2024-06-28 | ||||||
| 2022-12-31 | -$140.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$610.00K derived: sum of 2 quarters · filed 2024-06-06 | -$1.31M derived: sum of 3 quarters · filed 2024-06-06 | -$1.87M 10-K · filed 2024-06-06 | |||
| 2022-09-30 | -$470.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | -$1.17M derived: sum of 2 quarters · filed 2024-06-04 | -$1.73M 10-Q/A · filed 2024-06-04 | -$1.89M derived: sum of 4 quarters · filed 2024-06-04 | |||
| 2022-06-30 | -$702.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.26M 10-Q · filed 2023-08-10 | $90.55M 10-Q · filed 2022-08-12 | -$1.42M derived: sum of 3 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$558.00K 10-Q · filed 2023-05-11 | -$718.00K derived: sum of 2 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$355.00K 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | -$195.00K 10-Q · filed 2022-11-21 | ||||||
| 2020-12-31 | -$201.25M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |